Advertising
Agriculture
Airlines-Aviation
Aerospace-Defense
Art
Auto
Banking-Financial Services
Beer, Wine & Spirits
Biometrics
Biotechnology
Books
Charity
Chemical
Computer Electronics
Computer Gaming
Computer Hardware
Computer Networks
Computer Software
Construction-Building
Consumer Electronics
Death Care Services
Education
Electronic Commerce
Electronic Components
Electronic Design Automation
Electronics Performance Measurement
Entertainment
Environmental Services
Fashion
Film-Motion-Picture
Food-Beverages
Gambling-Casinos
Government
Health Care-Hospitals
High-Tech Security
Higher Education
Homeland Security
Household-Consumer-Cosmetics
Infectious Disease Control
Insurance
Internet Technology
Legal
Leisure-Travel-Hotels
Machinery
Magazines
Maritime-Shipbuilding
Medical-Pharmaceuticals
Mining-Metals
Mobile Entertainment
Multimedia-Online-Internet
Music
Mutual Funds
Nanotechnology
Office Products
Oil-Energy
Otc-Smallcap
Paper-Forest-Products-Containers
Peripherals
Publishing-Information Services
Radio
Real Estate
Religion
Restaurants
Retail
Safety
Semiconductors
Sports
Supermarkets
Supplementary Medicine
Telecommunications
Television
Temporary Staffing Services
Textiles
Tobacco
Transportation-Trucking-Railroad
Travel
Utilities
Workforce Management/Human Resources
News Releases For April 2, 2008

DermaGen AB Receives Over 1 Million Euros From a New Share Issue

Bavarian Nordic Update - 2007 Annual Results, IMVAMUNE(R) Delivery Contract, Strategy Process

PharmAthene Closes Acquisition of Avecia Biodefense Vaccines Business Unit

Proteolix's Carfilzomib Receives Orphan Drug Designation for Treatment of Multiple Myeloma

Monogram Biosciences Provides Progenics Pharmaceuticals with HIV Assays for Use in Clinical Trials

ThromboGenics Completes Patient Enrolment in the Phase IIb Trial of Microplasmin in Vitrectomy (MIVI III)

Study Confirms Anti-Infective ARIKACE(TM) Effectively Penetrates Mucus and Biofilm, and Kills Pseudomonas, a Bacteria Plaguing Cystic Fibrosis Patients

CV Therapeutics' Anti-Ischemic Therapy Ranexa(R) Significantly Reduces Cardiac Chest Pain Symptoms and Recurrent Ischemia in MERLIN-TIMI 36 Patients With Angina

Final Data From the SEISMIC Trial Suggest Safety, Efficacy of Autologous Stem- Cell Therapy for Treating Congestive Heart Failure

VWR International, LLC Acquires Jencons (Scientific) Ltd, UK


Issuers of news releases and not PR Newswire are solely responsible for the accuracy of the content.
Terms and conditions, including restrictions on redistribution, apply.
Copyright © 1996-2008 PR Newswire Association LLC. All Rights Reserved.
A United Business Media company.